RAILCAR
    3.
    发明申请
    RAILCAR 有权

    公开(公告)号:US20150203129A1

    公开(公告)日:2015-07-23

    申请号:US14414279

    申请日:2012-07-12

    IPC分类号: B61D15/06

    摘要: A railcar according to the present invention includes: an underframe including an end beam at its railcar-longitudinal-direction end portion; side bodyshells; a roof bodyshell; side outside plates respectively arranged at both railcar-width-direction end portions of the railcar and constituting the side bodyshells; corner posts extending from the end beam toward the roof bodyshell; and intermediate coupling members each configured to couple the side outside plate and the corner post, the stiffness of the intermediate coupling member in a railcar longitudinal direction being lower than the stiffness of the intermediate coupling member in a vertical direction.

    摘要翻译: 根据本发明的轨道车辆包括:底架,其在其轨道车纵向端部处包括端梁; 侧身体; 屋顶身体; 分别设置在轨道车厢的两个轨道车宽方向端部,并构成侧部机身; 角柱从端梁延伸到屋顶壳体; 以及中间联接构件,每个中间联接构件均被配置为联接侧面外侧板和角柱,中间联接构件在轨道车辆纵向方向上的刚度低于中间联接构件在垂直方向上的刚度。

    Medical adhesive
    5.
    发明授权
    Medical adhesive 有权
    医用胶

    公开(公告)号:US09421299B2

    公开(公告)日:2016-08-23

    申请号:US14005906

    申请日:2012-03-09

    摘要: The present invention is directed to providing a safe medical adhesive, a cured body of which is hard to be degraded and decomposed and thus stable and the cured body generates less amount of acid, aldehyde, etc. due to degradation/decomposition. The medical adhesive includes a hydrophilic urethane prepolymer (UP) obtained by reacting a polyisocyanate component (A) containing a fluorine-containing non-aromatic polyisocyanate compound (A1) as an essential ingredient and a polyol component (B) containing a hydrophilic polyol (B1) as an essential ingredient, wherein a chlorine content in a chlorine-containing organic compound based on the weight of the hydrophilic urethane prepolymer (UP) is 0.005 wt % or less.

    摘要翻译: 本发明旨在提供一种安全的医用粘合剂,其固化体难以降解和分解,因此稳定,固化体由于降解/分解而产生较少量的酸,醛等。 医用胶粘剂包括通过使含有含氟非芳香族多异氰酸酯化合物(A1)作为必需成分的多异氰酸酯成分(A)与含有亲水性多元醇(B1)的多元醇成分(B)反应而得到的亲水性氨基甲酸酯预聚物(UP) )作为必要成分,其中,基于亲水性氨基甲酸酯预聚物(UP)的重量,含氯有机化合物中的氯含量为0.005重量%以下。

    Rotation and extension/retraction link mechanism
    7.
    发明授权
    Rotation and extension/retraction link mechanism 有权
    旋转和伸展/缩回连杆机构

    公开(公告)号:US07926370B2

    公开(公告)日:2011-04-19

    申请号:US10596628

    申请日:2004-12-17

    IPC分类号: F16H21/00

    摘要: A rotation and extension/retraction link mechanism which realizes a rotary joint having a virtual rotation axis is provided. A rotation and extension/retraction link mechanism 1 is configured so that a first link 5 having a first virtual center line 3 and a second link 9 having a second virtual center line 7 are coupled through a rotation and extension/retraction joint mechanism 11. The rotation and extension/retraction joint mechanism 11 is configured to couple the first link 5 and the second link 9 so that when the second virtual center line 7 rotates relative to the first virtual center line 3 from a state where the first virtual center line 3 entirely overlaps with the second virtual center line 7, while crossing the first virtual center line 3, an intersection between the first virtual center line 3 and the second virtual center line 7 is displaced on the first virtual center line 3 by a predetermined distance corresponding to an angle of the rotation.

    摘要翻译: 提供实现具有虚拟旋转轴的旋转接头的旋转和延伸/缩回连杆机构。 旋转和延伸/缩回连杆机构1构造成使得具有第一虚拟中心线3的第一连杆5和具有第二虚拟中心线7的第二连杆9通过旋转和延伸/缩回接合机构11联接。 旋转和延伸/缩回关节机构11被配置为将第一连杆5和第二连杆9联接成使得当第二虚拟中心线7相对于第一虚拟中心线3从第一虚拟中心线3完全旋转的状态 与第二虚拟中心线7重叠,在穿过第一虚拟中心线3时,第一虚拟中心线3和第二虚拟中心线7之间的交点在第一虚拟中心线3上移位相应于 旋转角度。

    MEDICAL ADHESIVE
    10.
    发明申请
    MEDICAL ADHESIVE 有权
    医用胶粘剂

    公开(公告)号:US20140018510A1

    公开(公告)日:2014-01-16

    申请号:US14005906

    申请日:2012-03-09

    IPC分类号: A61L24/04

    摘要: The present invention is directed to providing a safe medical adhesive, a cured body of which is hard to be degraded and decomposed and thus stable and the cured body generates less amount of acid, aldehyde, etc. due to degradation/decomposition. The medical adhesive includes a hydrophilic urethane prepolymer (UP) obtained by reacting a polyisocyanate component (A) containing a fluorine-containing non-aromatic polyisocyanate compound (A1) as an essential ingredient and a polyol component (B) containing a hydrophilic polyol (B1) as an essential ingredient, wherein a chlorine content in a chlorine-containing organic compound based on the weight of the hydrophilic urethane prepolymer (UP) is 0.005 wt % or less.

    摘要翻译: 本发明旨在提供一种安全的医用粘合剂,其固化体难以降解和分解,因此稳定,固化体由于降解/分解而产生较少量的酸,醛等。 医用胶粘剂包括通过使含有含氟非芳香族多异氰酸酯化合物(A1)作为必需成分的多异氰酸酯成分(A)与含有亲水性多元醇(B1)的多元醇成分(B)反应而得到的亲水性氨基甲酸酯预聚物(UP) )作为必要成分,其中,基于亲水性氨基甲酸酯预聚物(UP)的重量,含氯有机化合物中的氯含量为0.005重量%以下。